Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo

Novel therapeutic targets are needed to better treat osteosarcoma, which is the most common bone malignancy. We previously developed mouse osteosarcoma cells, designated AX (accelerated bone formation) cells from bone marrow stromal cells. AX cells harbor both wild-type and mutant forms of p53 (R270...

Повний опис

Бібліографічні деталі

Автори:	Takatsune Shimizu, Eiji Sugihara, Hideyuki Takeshima, Hiroyuki Nobusue, Rui Yamaguchi, Sayaka Yamaguchi-Iwai, Yumi Fukuchi, Toshikazu Ushijima, Akihiro Muto, Hideyuki Saya
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-11-01
Серія:	Cells
Предмети:	osteosarcoma p53 mutant p53 metastasis
Онлайн доступ:	https://www.mdpi.com/2073-4409/11/22/3614
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!